Biotech

All Articles

Turnstone gives up 60%, shocks C-suite to extend money

.Turnstone Biologics is actually lessening its headcount through 60% and also shaking up its C-suite...

Gilead surrenders on $15M MASH wager after reviewing preclinical data

.In a year that has actually viewed a confirmation and also a raft of readouts for metabolic dysfunc...

Texas biotech axes cancer cells treaty, pins hopes on obesity

.Alaunos Rehabs is axing an agreement along with Precigen, giving up licensing legal rights to a tai...

Capricor portions extra information for DMD therapy after starting BLA

.Capricor Therapies is actually taking a victory tour for their stage 2 Duchenne muscle dystrophy (D...

FDA spots Kezar lupus test in hold following 4 client deaths

.The FDA has put Kezar Lifestyle Sciences' lupus trial on hold after the biotech flagged four fatali...

Phase 3 Intellectual Rock trial hits SMA goal, sending out stock up 200%

.A stage 3 test of Academic Stone's spinal muscular atrophy (SMA) candidate has actually struck its ...

CAMP 4 is most recent to eye IPO, while Upstream point out $182M strategy

.RNA biotech CAMP4 Rehabs has defined prepare for a $67 thousand IPO, along with inflammation-focuse...

Galecto purchases leukemia medication, drops bone cancer cells resource in pivot

.A year after the breakdown of an idiopathic lung fibrosis applicant delivered Galecto on a seek red...

Judo tosses down $100M to knock out kidney ailment

.Taking the mat is actually Judo Bio, an up-and-coming biotech armed with $100 million to build olig...

AstraZeneca spends CSPC $100M for preclinical heart disease drug

.AstraZeneca has paid CSPC Pharmaceutical Team $100 million for a preclinical cardiovascular disease...